These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
118 related articles for article (PubMed ID: 6744327)
1. Augmentation of autologous antibody to human melanoma following acid dissociation and ultrafiltration of serum. Kirkwood JM; Vlock DR Cancer Res; 1984 Sep; 44(9):4177-82. PubMed ID: 6744327 [TBL] [Abstract][Full Text] [Related]
2. Incidence of serum antibody reactivity to autologous head and neck cancer cell lines and augmentation of antibody reactivity following acid dissociation and ultrafiltration. Vlock DR; Scalise D; Schwartz DR; Richter DE; Krause CJ; Baker SR; Carey TE Cancer Res; 1989 Mar; 49(6):1361-5. PubMed ID: 2924293 [TBL] [Abstract][Full Text] [Related]
3. Isolation and immunochemical characterization of antibodies from the sera of cancer patients which are reactive against human melanoma cell membranes by affinity chromatography. Gupta RK; Silver HK; Reisfeld RA; Morton DL Cancer Res; 1979 May; 39(5):1683-95. PubMed ID: 427806 [TBL] [Abstract][Full Text] [Related]
4. Serial studies of autologous antibody reactivity to melanoma. Relationship to clinical course and circulating immune complexes. Vlock DR; Kirkwood JM J Clin Invest; 1985 Aug; 76(2):849-54. PubMed ID: 3875634 [TBL] [Abstract][Full Text] [Related]
5. [Serological analysis of melanoma patients receiving autologous melanoma cell vaccines]. Watanabe T Gan To Kagaku Ryoho; 1983 Feb; 10(2 Pt):261-72. PubMed ID: 6881976 [TBL] [Abstract][Full Text] [Related]
6. Prolonged survival for melanoma patients with elevated IgM antibody to oncofetal antigen. Jones PC; Sze LL; Liu PY; Morton DL; Irie RF J Natl Cancer Inst; 1981 Feb; 66(2):249-54. PubMed ID: 6935475 [TBL] [Abstract][Full Text] [Related]
7. Induction of IgG antibodies directed to a M(r) 31,000 melanoma antigen in patients immunized with vaccinia virus melanoma oncolysates. Berthier-Vergnes O; Portoukalian J; Lefthériotis E; Doré JF Cancer Res; 1994 May; 54(9):2433-9. PubMed ID: 8162593 [TBL] [Abstract][Full Text] [Related]
8. Oncofetal antigen: a tumor-associated fetal antigen immunogenic in man. Irie RF; Giuliano AE; Morton DL J Natl Cancer Inst; 1979 Aug; 63(2):367-73. PubMed ID: 88539 [TBL] [Abstract][Full Text] [Related]
9. Changes in distribution of human malignant melanoma membrane antigens in the presence of human antibody by immunofluorescence. Leong SP; Sutherland CM; Krementz ET Cancer Res; 1977 Jan; 37(1):293-8. PubMed ID: 318607 [TBL] [Abstract][Full Text] [Related]
10. Antibody-induced movement of common melanoma membrane antigens on the surface of unfixed human melanoma cells. Leong SP; Cooperband SR; Deckers PJ; Sutherland CM; Cesare JF; Krementz ET Cancer Res; 1979 Jun; 39(6 Pt 1):2125-31. PubMed ID: 376115 [TBL] [Abstract][Full Text] [Related]
11. Production of antisera with specificity for malignant melanoma and human fetal skin. Fritze D; Kern DH; Drogemuller CR; Pilch YH Cancer Res; 1976 Feb; 36(2 Pt 1):458-66. PubMed ID: 56991 [TBL] [Abstract][Full Text] [Related]
12. Mouse monoclonal antibody to a melanoma-carcinoma-associated antigen synthesized by a human melanoma cell line propagated in serum-free medium. Chee DO; Yonemoto RH; Leong SP; Richards GF; Smith VR; Klotz JL; Goto RM; Gascon RL; Drushella MM Cancer Res; 1982 Aug; 42(8):3142-7. PubMed ID: 7046918 [TBL] [Abstract][Full Text] [Related]
13. 707-AP peptide recognized by human antibody induces human leukocyte antigen A2-restricted cytotoxic T lymphocyte killing of melanoma. Takahashi T; Irie RF; Nishinaka Y; Hoon DS Clin Cancer Res; 1997 Aug; 3(8):1363-70. PubMed ID: 9815820 [TBL] [Abstract][Full Text] [Related]
14. Monoclonal antibodies to human melanoma-associated antigens: an amplified enzyme-linked immunosorbent assay for the detection of antigen, antibody, and immune complexes. Morgan AC; McIntyre RF Cancer Res; 1983 Jul; 43(7):3155-9. PubMed ID: 6850625 [TBL] [Abstract][Full Text] [Related]
15. [Vaccine therapy of malignant melanoma. II. Serological evaluation of the immune responses to the injection using allogeneic melanoma cell vaccine]. Takeyama H; Watanabe T; Livingston PO Gan To Kagaku Ryoho; 1983 Jul; 10(7):1624-33. PubMed ID: 6870307 [TBL] [Abstract][Full Text] [Related]
16. Tumor antigens isolated from a patient with vitiligo and T-cell-infiltrated melanoma. Kiniwa Y; Fujita T; Akada M; Ito K; Shofuda T; Suzuki Y; Yamamoto A; Saida T; Kawakami Y Cancer Res; 2001 Nov; 61(21):7900-7. PubMed ID: 11691810 [TBL] [Abstract][Full Text] [Related]
17. Prognostic role of antibody reactivity to melanoma. Vlock DR; DerSimonian R; Kirkwood JM J Clin Invest; 1986 Apr; 77(4):1116-21. PubMed ID: 3958183 [TBL] [Abstract][Full Text] [Related]
18. Melanoma-reactive human cytotoxic T lymphocytes derived from skin biopsies of delayed-type hypersensitivity reactions induced by injection of an autologous melanoma cell line. Waanders GA; Rimoldi D; Liénard D; Carrel S; Lejeune F; Dietrich PY; Cerottini JC; Romero P Clin Cancer Res; 1997 May; 3(5):685-96. PubMed ID: 9815737 [TBL] [Abstract][Full Text] [Related]
19. Suggestive evidence for in vivo binding of specific antitumor antibodies of human melanomas. Gupta RK; Morton DL Cancer Res; 1975 Jan; 35(1):58-62. PubMed ID: 1109797 [TBL] [Abstract][Full Text] [Related]
20. Cytotoxic antibody reactivity in sera of melanoma patients against allogeneic and autologous cultured tumor cells and fibroblasts. Brown JM; Shoffner PC; Tondreau SP; Matthews EJ; Terry WD; Rosenberg SA Cancer Res; 1982 Jun; 42(6):2216-22. PubMed ID: 7074602 [No Abstract] [Full Text] [Related] [Next] [New Search]